[Illustration: ipopba/iStock]
Our capital, Austin, has a reputation for attracting businesses at the cutting edge of the sciences, but it is hardly the only bright spot for innovation in the Lone Star State. In fact, venture capital funding is flowing into Dallas-Fort Worth at a faster rate than any other area in the nation. When it comes to the biotech industry, our region is leading the U.S. in key metrics of job growth and investment.
This success in North Texas is not a coincidence, but the result of strategic collaborative efforts and a shared ambition of key players across this regions biotech ecosystem. The collective efforts of government, nonprofit, academic, and industry partners have brought together the necessary ingredients to enable sustainable long-term growth.
Emblematic of this collaboration is the forthcoming Texas Instruments Biomedical Engineering and Sciences Building, a joint partnership between UT Southwestern Medical Center and The University of Texas at Dallas. By integrating biomedical engineering with advances in related fields such as artificial intelligence, molecular imaging, robotics, and genetic engineering, this collaboration will further solidify North Texas reputation as a hot market for biomedical innovation.
The quality of innovation emanating from our nationally ranked hospital systems and research centers can be credited in a large part for growing investor interest. But good science alone isnt enough. DFW produces, attracts, and retains the skilled workforce our industry partners need to scale up operations. This has paved the way for companies like Taysha Gene Therapies and Caris Life Sciences to make the strategic decision to headquarter and innovate here.
Another indicator of our regions long-term stability is Biolabs selection of Dallas as its ninth location in the U.S. This brand-new 32,000-square-foot flexible lab, training, and office space at Pegasus Park has addressed a previously critically deficient element of our healthcare innovation ecosystem. DFWs historic lack of available commercial laboratory space has been a recognized hindrance to the growth and retention of the early-stage startups that are the lifeblood of this industry. This available lab space is in high demand and is on track to achieve full occupancy in the short term.
Kendall Square (in Cambridge, MA), South San Francisco, and La Jolla (north of San Diego) are all power clusters that have pulled away several of our regions innovators and their startup companies through the undeniable allure of easy flow of venture capital dollars and access to a highly skilled workforce. These same regions are now facing their own challenges, from unaffordable housing to urban congestion, that are causing real reductions in quality-of-life metrics. In that respect, our timing couldnt be better to support critical elements that will enable continued biopharma and healthcare innovation growth.
In fact, we possess another enormous asset that those other innovation hubs do not. Dallas Fort Worth International Airports cold chain logistics capabilities enable the distribution of fragile biologic and pharmaceutical medicines to anywhere in the world in a matter of hours while maintaining essential and highly specific conditions. Only one other airport in the U.S. possesses logistics close to this scale.
DFW further benefits from fantastic state and local government partners in driving sound economic development choices that are supporting our growth as a biotech hub. These capabilities and our famously business friendly environment attracted McKesson, the nations largest pharmaceutical distributor, to relocate to North Texas four years ago.
The rapid rise of Pegasus Park as the center of our regions life sciences hub now equips North Texas with its own hugely scalable version of the clusters found on the coasts. Similarly, plans have been announced for Texas A&M to expand their Fort Worth presence with a research campus that will advance medical innovation and drive business development. In order to maintain this momentum and realize significant industry growth, we must continue to build and improve access to ready capital for investment in all stages of biopharma innovation.
Other national partners like MassChallenge have begun to make an impact by creating the environment needed to promote and attract access to funding and entrepreneurial resources. BioNORTHTEXAS is also developing our own Investor Forum that will soon attract national funding partners as we match them with researchers and startups.
With government, industry, and academia working together, there is not a problem that we cannot solve. This is an exciting time for our industry and region as we drive towards a more innovative and prosperous future.
Views and opinions expressed by Voices contributors are their own.
Kathleen Otto (left) and George Goodno
Kathleen Otto is the CEO at BioNORTHTEXAS. She previously served as executive director of New York Citys Science and Technology Center at the Brooklyn Army Terminal, and as Vice President of Business Development and Programs at Bio New Jersey.
George Goodno is a Senior Advisor for the ENTENTE Network, providing communications and management consulting services to biopharma and healthcare clients. Previously he served as the Director of Industry Relations for UT Southwesterns Office for Technology Development and Director of Communications for the national trade group Biotechnology Innovation Organization. Goodno presently serves on advisory councils for BioNTX and Healthcare Think Tank.
Sign up to keep your eye on whats new and next in Dallas-Fort Worth, every day.
BioLabs at Pegasus Park shared space and state-of-the-art lab is slated to open in December. It's a place where entrepreneurial innovators can test, develop, and grow their ideas.
Rare is not that rare, says the RDCC. One in ten people lives with a rare disease, and the new coalition will unify life science companies dedicated to developing treatments. The goal? To inform policymakers of the unique challenges in the space. Signature Biologics joins Dallas-based Taysha as a member of the RDCC.
The summit is an innovation multiplier for capital, collaboration, and commercialization. Plus, you can meet 2021 NTX Rising Starsand the new companies moving to BioLabs at Pegasus Park. Here's an updated agenda for the annual iC3 Life Science Summit on September 30 and October 1.
Now valued at more than $7.8 billion, Caris specializes in AI-powered genetic sequencing for personalized cancer treatments. The massive capital raise follows a $310 million round in October and boosts the 13-year-old company's total funding to about $1.3 billion.
The agreement will involve the two companies providing educational programs and connections for scientist entrepreneurs located at the Biotech+ Hub at Pegasus Park.
As the former CEO of the Perot Museum of Nature and Science from 2002 to 2014, Nicole Smalls passion for philanthropy and STEM education firmly prepared her for her current role as president of the Lyda Hill Foundation and CEO of LH Holdings Inc.
Biotechnology is alive and growing in DFW. The region recently ranked 6th on a list of top ten emerging life science clusters in the U.S.
Pharma relocations, venture capital, and $6 billion in the State of Texas CPRIT Fund are priming North Texas to be a life sciences mecca, says Transwestern's John Huff.
Alcon gave rise to a startup ecosystem in North Texas that is spreading into all parts of how drugs, medical devices, and more are created.
See the rest here:
Collaboration Is the Key to North Texas' Emergence as a Bio-Hub Dallas Innovates - dallasinnovates.com
- Viewpoint: Anti-GMO arguments seem silly after 28 years of false narratives about health harms and and genetic ... - Genetic Literacy Project - March 29th, 2024 [March 29th, 2024]
- Viewpoint: Here's how genetically engineered fruits and vegetables will soon emerge as a grocery store 'selling point ... - Genetic Literacy Project - March 29th, 2024 [March 29th, 2024]
- CRISPR Investments: What We Heard at World Agri-Tech - Seed World - March 29th, 2024 [March 29th, 2024]
- When SpaceX's Starship is ready to settle Mars, will we be? (op-ed) - Space.com - September 17th, 2023 [September 17th, 2023]
- Genome-wide promoter responses to CRISPR perturbations of ... - Nature.com - September 17th, 2023 [September 17th, 2023]
- Expanding the toolbox for RNA editing | ASU News - ASU News Now - September 17th, 2023 [September 17th, 2023]
- Electrical Engineer Named MIT Technology Review Innovator Under ... - University of California San Diego - September 17th, 2023 [September 17th, 2023]
- Can we rely on our 'moral force-field' to stop cloning going too far? - The National - September 17th, 2023 [September 17th, 2023]
- Otsuka Collaborates with ShapeTX for Development of AAV Gene ... - Pharmaceutical Technology Magazine - September 17th, 2023 [September 17th, 2023]
- Cancer discovery earns U of A grad the Breakthrough Prize - University of Alberta - September 17th, 2023 [September 17th, 2023]
- The Brave New World of synthetic humans | Gne Taylor - IAI - September 17th, 2023 [September 17th, 2023]
- Targeting Tumors with Photosynthetic Bacteria - Optics & Photonics News - September 17th, 2023 [September 17th, 2023]
- Artificial Photosynthesis Breakthrough Researchers Produce ... - SciTechDaily - September 17th, 2023 [September 17th, 2023]
- BASF patent on watermelons upheld: European Patent Office rejects ... - Bio Eco Actual - September 17th, 2023 [September 17th, 2023]
- Space Industry Is Growing Faster Than Its Workforce, Analysts Say - Slashdot - September 17th, 2023 [September 17th, 2023]
- New 'Inverse Vaccine' Shows Potential to Treat MS and Other ... - Slashdot - September 17th, 2023 [September 17th, 2023]
- Gene therapy: Donor DNA may protect babies from certain disorders - Medical News Today - May 18th, 2023 [May 18th, 2023]
- Viewpoint: Grim consequences of Greenpeace's war on ... - Genetic Literacy Project - May 18th, 2023 [May 18th, 2023]
- Predicting Diabetic Kidney Disease with the Use of a Novel Algorithm - Genetic Engineering & Biotechnology News - May 18th, 2023 [May 18th, 2023]
- Quantum biology on horizon? How futuristic physics theory could ... - Study Finds - May 18th, 2023 [May 18th, 2023]
- Scientists can collect human DNA from water, air, and basically ... - Earth.com - May 18th, 2023 [May 18th, 2023]
- The First Crispr-Edited Salad Is Here - WIRED - May 18th, 2023 [May 18th, 2023]
- Gene editing technology used to produce disease-resistant calf - Earth.com - May 18th, 2023 [May 18th, 2023]
- Neanderthals passed down their tall noses to modern humans ... - Livescience.com - May 18th, 2023 [May 18th, 2023]
- Squid Camouflage Inspires Human Invisibility: Is it Possible? - DISCOVER Magazine - May 18th, 2023 [May 18th, 2023]
- Mice Model Technologies Market Poised for 7.4% CAGR Growth, Reaching USD 3.2 Bn by 2031 | Transparency Market Research - Yahoo Finance - May 18th, 2023 [May 18th, 2023]
- Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine - CNBC - May 18th, 2023 [May 18th, 2023]
- How Fauci, scientists with ties to Wuhan lab persuaded the ... - U.S. Right to Know - May 18th, 2023 [May 18th, 2023]
- The Daunting Task of Cutting Heavy Metals from Baby Food - Undark Magazine - May 18th, 2023 [May 18th, 2023]
- Ingestible Device Profiles and Peers into the Microbiome and ... - Genetic Engineering & Biotechnology News - May 18th, 2023 [May 18th, 2023]
- X-Men Officially Names the Best Powers Any Mutant Can Have - Screen Rant - May 18th, 2023 [May 18th, 2023]
- 10 Forgotten Marvel Comics Characters That Debuted In The '80s - Screen Rant - May 18th, 2023 [May 18th, 2023]
- 18 Human Genetic Engineering - Clemson University - April 19th, 2023 [April 19th, 2023]
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 31st, 2023 [March 31st, 2023]
- What is Genetic Engineering? Types, Process & Applications - March 31st, 2023 [March 31st, 2023]
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 31st, 2023 [March 31st, 2023]
- Welcome to the UNC Department of Genetics | Department of Genetics - February 5th, 2023 [February 5th, 2023]
- Global Genetically Modified Crops Market Is Projected To Grow At A 6% Rate Through The Forecast Period - EIN News - February 5th, 2023 [February 5th, 2023]
- Science and History of GMOs and Other Food Modification Processes - February 2nd, 2023 [February 2nd, 2023]
- Genetics | History, Biology, Timeline, & Facts | Britannica - January 31st, 2023 [January 31st, 2023]
- Human genetics | Description, Chromosomes, & Inheritance - January 31st, 2023 [January 31st, 2023]
- Genetic testing - Mayo Clinic - January 31st, 2023 [January 31st, 2023]
- Genetic Disorders: What Are They, Types, Symptoms & Causes - January 31st, 2023 [January 31st, 2023]
- Colossal Biosciences Project to Revive the Prehistoric Woolly Mammoth Raises Staggering $60 Million Series A Funding - Nature World News - January 22nd, 2023 [January 22nd, 2023]
- 2023 is going to witness a surge in technology courses top courses that will remain in vogue - Times of India - January 22nd, 2023 [January 22nd, 2023]
- M.R.S. Rao birthday: All you need to know about the Padma Shri winning Indian scientist - Free Press Journal - January 22nd, 2023 [January 22nd, 2023]
- Russian cosmism - Wikipedia - January 8th, 2023 [January 8th, 2023]
- Postgenderism - Wikipedia - January 8th, 2023 [January 8th, 2023]
- LessWrong - Wikipedia - January 8th, 2023 [January 8th, 2023]
- Eliezer Yudkowsky - Wikipedia - January 8th, 2023 [January 8th, 2023]
- Genetic Engineering Principles of Biology - December 26th, 2022 [December 26th, 2022]
- Engineering the Perfect Baby | MIT Technology Review - December 26th, 2022 [December 26th, 2022]
- Genetic Engineering Science Projects - Science Buddies - December 21st, 2022 [December 21st, 2022]
- DSI adoption at COP15 can financially help protect biodiversity in India: Experts - The Tribune India - December 21st, 2022 [December 21st, 2022]
- Tel Aviv University researchers demonstrate success of potential one-time vaccine to treat HIV/AIDS - ETHealthWorld - December 21st, 2022 [December 21st, 2022]
- Should You Buy 22nd Century Group Inc (XXII) Stock After it Has Risen 14.29% in a Week? - InvestorsObserver - October 28th, 2022 [October 28th, 2022]
- Home :: National Institute for Biotechnology and Genetic Engineering - October 11th, 2022 [October 11th, 2022]
- A recently discovered law of physics could help predict genetic mutations - October 11th, 2022 [October 11th, 2022]
- Farmers, consumers will embrace GMOs if they understand them - The Standard - October 11th, 2022 [October 11th, 2022]
- Synthetic Biology Market is Expected to Report a CAGR of ~21% from 2021 to 2029: Industry Size, Growth & Forecast at Douglas Insights - Yahoo... - October 11th, 2022 [October 11th, 2022]
- After 45 years of science-based art, Esther Klein Gallery winds down - WHYY - October 11th, 2022 [October 11th, 2022]
- Behind this Nobel prize is a very human story: theres a bit of Neanderthal in all of us - The Guardian - October 11th, 2022 [October 11th, 2022]
- The key to tastier beer might be mutant yeastwith notes of banana - Popular Science - October 11th, 2022 [October 11th, 2022]
- Why You'll Probably Never See Cotton Candy Grape Wine - Tasting Table - October 11th, 2022 [October 11th, 2022]
- Earth materials in technology The National - The National - October 11th, 2022 [October 11th, 2022]
- CULINARY THRILL SEEKING Proceed with caution. It's hotter than blazes season. - Port Arthur News - The Port Arthur News - October 11th, 2022 [October 11th, 2022]
- Give legal rights to animals, trees and rivers, say experts - The Guardian - October 11th, 2022 [October 11th, 2022]
- How yeast DNA may help protect astronauts from cosmic radiation in space - EastMojo - October 11th, 2022 [October 11th, 2022]
- Life finds a way, but should it? The ethics of genetic engineering - The Trinitonian - October 8th, 2022 [October 8th, 2022]
- To modify or not to modify? Genetic Modification and Gene Editing - A divergence by the UK - Lexology - October 8th, 2022 [October 8th, 2022]
- Gene Therapy Hits Its Stride in the Clinic - Genetic Engineering & Biotechnology News - October 8th, 2022 [October 8th, 2022]
- GWAS, MWAS and mGWAS provide insights into precision agriculture based on genotype-dependent microbial effects in foxtail millet - Nature.com - October 8th, 2022 [October 8th, 2022]
- Making Sense of the Latest Apple-iPhone News - The Motley Fool - October 8th, 2022 [October 8th, 2022]
- Gene therapy brings hope to people with sickle cell, HIV - Monitor - October 8th, 2022 [October 8th, 2022]
- GMO: Everything you need to know about lifting ban - FarmKenya Initiative - The Standard - October 8th, 2022 [October 8th, 2022]
- Century Therapeutics to Present at the SITC 37th Annual Meeting - Yahoo Finance - October 8th, 2022 [October 8th, 2022]
- Cultured meat could help solve the climate crisis. Heres what it will take to move it from the lab to the dinner table - Fortune - October 8th, 2022 [October 8th, 2022]
- Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting -... - October 8th, 2022 [October 8th, 2022]
- Explained: How scientists engineered mosquitoes that will cut the transmission of malaria - Firstpost - October 8th, 2022 [October 8th, 2022]
- Here Are the Biggest Health Industry News Items of 2022 So Far - DocWire News - October 8th, 2022 [October 8th, 2022]